Longeveron Inc(LGVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LGVN Longeveron Inc

Market Closed 07-17 16:00:00 EDT

0.6220

+0.0086

+1.40%

盘后0.6248

+0.0028+0.45%

19:54 EDT

High0.6275	Low0.5949	Vol202.18K
Open0.6134	D1 Closing0.6134	Amplitude5.31%
Mkt Cap19.65M	Tradable Cap16.95M	Total Shares31.60M
T/O123.57K	T/O Rate0.74%	Tradable Shares27.26M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LGVN","market":"US","secType":"STK","nameCN":"Longeveron Inc","latestPrice":0.622,"timestamp":1784318400000,"preClose":0.6134,"halted":0,"volume":202176,"hourTrading":{"tag":"盘后","latestPrice":0.6248,"preClose":0.622,"latestTime":"19:54 EDT","volume":389,"amount":242.27552,"timestamp":1784332479544,"change":0.0028,"changeRate":0.004502,"amplitude":0.004502},"delay":0,"changeRate":0.014020215194000738,"floatShares":27255300,"shares":31597952,"eps":-1.119466,"marketStatus":"Market Closed","change":0.0086,"latestTime":"07-17 16:00:00 EDT","open":0.6134,"high":0.62745,"low":0.5949,"amount":123572.31644159999,"amplitude":0.053065,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.119466,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1784534400000},"marketStatusCode":7,"adr":0,"listingDate":1613106000000,"exchange":"NASDAQ","adjPreClose":0.6134,"postHourTrading":{"tag":"盘后","latestPrice":0.6248,"preClose":0.622,"latestTime":"19:54 EDT","volume":389,"amount":242.27552,"timestamp":1784332479544,"change":0.0028,"changeRate":0.004502,"amplitude":0.004502},"volumeRatio":1.037874},"requestUrl":"/m/hq/s/LGVN","defaultTab":"news","newsList":[{"id":"2651445831","title":"Longeveron Enhances CEO Compensation and Retention Protections","url":"https://stock-news.laohu8.com/highlight/detail?id=2651445831","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651445831?lang=en_us&edition=fundamental","pubTime":"2026-07-15 15:30","pubTimestamp":1784100643,"startTime":"0","endTime":"0","summary":"Longeveron ( ($LGVN) ) has provided an update. On July 8, 2026, Longeveron Inc. entered into a revised employment letter agreement with Chief Execu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/longeveron-enhances-ceo-compensation-and-retention-protections?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/longeveron-enhances-ceo-compensation-and-retention-protections?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651484193","title":"Longeveron Director Arjun JJ Desai Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2651484193","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651484193?lang=en_us&edition=fundamental","pubTime":"2026-07-15 06:00","pubTimestamp":1784066446,"startTime":"0","endTime":"0","summary":"Longeveron director Arjun JJ Desai files initial beneficial ownership statementLongeveron director Arjun JJ Desai filed an initial Form 3 beneficial ownership statement dated July 2, 2026.Disclaimer:T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL3lQMqN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651484846","title":"Longeveron CEO Willard Base Salary Rises to $500,000 Under Revised Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2651484846","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651484846?lang=en_us&edition=fundamental","pubTime":"2026-07-15 05:20","pubTimestamp":1784064034,"startTime":"0","endTime":"0","summary":"Longeveron CEO Willard base salary rises to $500,000 under revised agreementLongeveron revised CEO Stephen Willard’s employment letter agreement on July 8, 2026, ending the prior deferral condition on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDLbFLQYj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651142923","title":"Longeveron Files Form 3 for Director Leah Rush Cann","url":"https://stock-news.laohu8.com/highlight/detail?id=2651142923","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651142923?lang=en_us&edition=fundamental","pubTime":"2026-07-14 06:00","pubTimestamp":1783980046,"startTime":"0","endTime":"0","summary":"Longeveron files Form 3 for director Leah Rush CannLongeveron director Cann Leah Rush filed an initial Form 3 disclosure dated July 1, 2026.Disclaimer:This news brief was created by Public Technologie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL2bGfmS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651611529","title":"Longeveron Says Stem Cell Therapy Laromestrocel Reduces Neuroinflammation in Phase 2a Mild Alzheimer’s Trial Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2651611529","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651611529?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:06","pubTimestamp":1783940802,"startTime":"0","endTime":"0","summary":"Longeveron says stem cell therapy laromestrocel reduces neuroinflammation in Phase 2a mild Alzheimer’s trial analysisLongeveron disclosed additional Phase 2a CLEAR-MIND analyses showing laromestrocel ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL3Hj0xf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2210150020.SGD","NDAQ","BK4112","SG9999014005.SGD","BCDF","IE00BN0W2T93.GBP","LU2095319765.USD","BK4585","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BKPKM429.USD","SG9999014039.USD","IE00BGHQF748.EUR","LGVN","LU2210149790.SGD","SG9999014013.SGD","IE00B64PRP62.GBP","LU0314104364.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650937916","title":"Longeveron grants special equity awards to Executive Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2650937916","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650937916?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:31","pubTimestamp":1783542705,"startTime":"0","endTime":"0","summary":"Longeveron ( ($LGVN) ) has shared an announcement. On July 6, 2026, Longeveron, Inc. granted special equity awards to its Executive Chairman under ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/longeveron-grants-special-equity-awards-to-executive-chairman?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/longeveron-grants-special-equity-awards-to-executive-chairman?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650915148","title":"Longeveron Grants Executive Chairman 1 Million Special Equity Awards Tied to Financing, Continued Service","url":"https://stock-news.laohu8.com/highlight/detail?id=2650915148","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650915148?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:09","pubTimestamp":1783541355,"startTime":"0","endTime":"0","summary":"Longeveron grants executive chairman 1 million special equity awards tied to financing, continued serviceLongeveron issued special equity awards to its executive chairman on July 6, 2026 under its ame","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL6XHPjC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649674514","title":"Longeveron strengthens financial leadership with new CFO appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2649674514","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649674514?lang=en_us&edition=fundamental","pubTime":"2026-07-07 05:27","pubTimestamp":1783373260,"startTime":"0","endTime":"0","summary":"Longeveron ( ($LGVN) ) has issued an update. Longeveron Inc., a clinical-stage biotech focused on stem cell-based regenerative therapies for rare p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/longeveron-strengthens-financial-leadership-with-new-cfo-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/longeveron-strengthens-financial-leadership-with-new-cfo-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LGVN","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649051679","title":"Longeveron appoints Marie Washburn CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2649051679","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649051679?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:10","pubTimestamp":1783368628,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN) announced that the company has appointed Marie Washburn to the company’s executive leadership team in the role of senior VP and C...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeveron-appoints-marie-washburn-cfo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeveron-appoints-marie-washburn-cfo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679102","title":"Longeveron Names Marie Washburn CFO, Replacing Lisa Locklear","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679102","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679102?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:09","pubTimestamp":1783368543,"startTime":"0","endTime":"0","summary":"Longeveron names Marie Washburn CFO, replacing Lisa LocklearLongeveron named Marie Washburn senior vice president, chief financial officer, principal financial officer, principal accounting officer, e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL4PPKp1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0683600562.USD","LU2347655156.SGD","LU1718418525.SGD","LU1894683264.USD","LU0124676726.USD","LU1267930813.SGD","LU0820561818.USD","LU1244550221.USD","VHT","IYH","LU2403377893.USD","JNJ","LU1914381329.SGD","LU0098860793.USD","FHLC","BK4559","IE00BFTCPJ56.SGD","LU0689472784.USD","GDOC","LU1196500208.SGD","LU1506573853.SGD","LU1778281490.HKD","LU0943347566.SGD","LU1145028129.USD","LU1935042991.SGD","LU2592432038.USD","RXL","LU0545562505.USD","SG9999001440.SGD","IE00B19Z3581.USD","MEDX","IE00BLSP4452.SGD","BMED","LU2756315318.SGD","XLV","LU0070217475.USD","LU0210536198.USD","LU1221951046.USD","LU2129689605.HKD","JDOC","IXJ","IE0000B7K699.USD","LGVN","FTXH","LU1162221912.USD","IHE","PJP","IE000WAW04H5.SGD","LU1732799900.SGD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649913679","title":"Longeveron® Appoints Marie Washburn as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2649913679","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649913679?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:05","pubTimestamp":1783368301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA8FBGZQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679918","title":"Longeveron - Marie Washburn Succeeds Lisa Locklear as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679918","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679918?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:05","pubTimestamp":1783368301,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA8FBGZQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649799206","title":"Press Release: Longeveron(r) Appoints Marie Washburn as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2649799206","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649799206?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:05","pubTimestamp":1783368300,"startTime":"0","endTime":"0","summary":"-- Ms. Washburn has over 20 years of experience in leadership roles in the. -- Corporate focus on delivering top-line results from the Phase 2b clinical. trial evaluating its stem cell therapy in Hypoplastic Left Heart Syndrome","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4575","R","LGVN","MSC","BK4150","EMM","IBB","BK4022","SYNB","BK4585","BK4232","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644086763","title":"Longeveron says new Phase 2a analysis of laromestrocel in mild Alzheimer’s accepted for AAIC 2026 poster presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2644086763","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644086763?lang=en_us&edition=fundamental","pubTime":"2026-06-18 21:20","pubTimestamp":1781788821,"startTime":"0","endTime":"0","summary":"Longeveron flagged an additional analysis from its Phase 2a CLEAR MIND study of laromestrocel in mild Alzheimer’s disease.Results were already published in Nature Medicine in March 2025, supporting potential benefit and backing continued clinical development.The new analysis will be presented at the 2026 Alzheimer’s Association International Conference in London on July 13.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL7RjP7p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","SG9999014005.SGD","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014013.SGD","BK4585","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","IE00BKPKM429.USD","LGVN","LU0314104364.USD","SG9999014039.USD","BK4112","NDAQ","LU2210149790.SGD","LU2095319765.USD","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642427498","title":"Longeveron wins EMA small, medium-sized enterprise status","url":"https://stock-news.laohu8.com/highlight/detail?id=2642427498","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642427498?lang=en_us&edition=fundamental","pubTime":"2026-06-09 21:26","pubTimestamp":1781011562,"startTime":"0","endTime":"0","summary":"Longeveron received small or medium-sized enterprise status from the European Medicines Agency, a designation that can lower fees.Status also supports earlier regulatory engagement during development of its lead cell therapy candidate laromestrocel .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longeveron Inc. published the original content used to generate this news brief on June 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL5zzsHF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642498113","title":"Longeveron Granted Small or Medium-Sized Enterprise (SME) Status by the European Medicines Agency (Ema)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642498113","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642498113?lang=en_us&edition=fundamental","pubTime":"2026-06-09 21:20","pubTimestamp":1781011200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nTUABRCPXX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642498269","title":"Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642498269","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642498269?lang=en_us&edition=fundamental","pubTime":"2026-06-09 21:20","pubTimestamp":1781011200,"startTime":"0","endTime":"0","summary":"MIAMI, June  09, 2026  (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-rel","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/09/3308957/0/en/Longeveron-Granted-Small-or-Medium-sized-Enterprise-SME-Status-by-the-European-Medicines-Agency-EMA.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4081","BK4575","EPV","BK4150","EMA","MDCO","MSC","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641412832","title":"Longeveron Announces CFO Transition to Internal Successor","url":"https://stock-news.laohu8.com/highlight/detail?id=2641412832","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641412832?lang=en_us&edition=fundamental","pubTime":"2026-06-06 05:19","pubTimestamp":1780694382,"startTime":"0","endTime":"0","summary":"Longeveron ( ($LGVN) ) has shared an announcement. On June 1, 2026, Longeveron Inc. announced that Chief Financial Officer Lisa Locklear will step ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/longeveron-announces-cfo-transition-to-internal-successor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/longeveron-announces-cfo-transition-to-internal-successor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641140304","title":"BRIEF-Longeveron -   On June 1, Lisa Locklear To Step Down As CFO Effective July 10, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2641140304","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641140304?lang=en_us&edition=fundamental","pubTime":"2026-06-06 04:35","pubTimestamp":1780691728,"startTime":"0","endTime":"0","summary":"BRIEF-Longeveron -   On June 1, Lisa Locklear To Step Down As CFO Effective July 10, 2026 - SEC FilingJune 5  - Longeveron Inc LGVN.O:LONGEVERON -   ON JUNE 1, LISA LOCKLEAR TO STEP DOWN AS CFO EFFECTIVE JULY 10, 2026 - SEC FILINGLONGEVERON - ANTICIPATES MARIE WASHBURN TO BE ELEVATED TO CFO PENDING FINAL CONTRACT - SEC FILINGSource text: [ID:n0001213900-26-065788]Further company coverage: LGVN.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nFWN42D05C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641147045","title":"Longeveron -   on June 1, Lisa Locklear to Step Down as CFO Effective July 10, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2641147045","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641147045?lang=en_us&edition=fundamental","pubTime":"2026-06-06 04:24","pubTimestamp":1780691047,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nFWN42D05C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.longeveron.com","stockEarnings":[{"period":"1week","weight":-0.0785},{"period":"1month","weight":-0.2595},{"period":"3month","weight":-0.4345},{"period":"6month","weight":0.1268},{"period":"1year","weight":-0.5961},{"period":"ytd","weight":0.2292}],"compareEarnings":[{"period":"1week","weight":-0.0154},{"period":"1month","weight":0.0031},{"period":"3month","weight":0.0467},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1835},{"period":"ytd","weight":0.09}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, a candidate in Phase 2a/b trials that is used for the treatment of alzheimer's disease, hypoplastic left heart syndrome, and aging-related frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.146765},{"month":2,"riseRate":0,"avgChangeRate":-0.052773},{"month":3,"riseRate":0.5,"avgChangeRate":0.193379},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.138428},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.132971},{"month":6,"riseRate":0.666667,"avgChangeRate":0.086991},{"month":7,"riseRate":0.5,"avgChangeRate":0.135156},{"month":8,"riseRate":0,"avgChangeRate":-0.329414},{"month":9,"riseRate":0.2,"avgChangeRate":-0.104571},{"month":10,"riseRate":0.4,"avgChangeRate":-0.0027},{"month":11,"riseRate":0.4,"avgChangeRate":1.29104},{"month":12,"riseRate":0,"avgChangeRate":-0.282059}],"exchange":"NASDAQ","name":"Longeveron Inc","nameEN":"Longeveron Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Longeveron Inc(LGVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Longeveron Inc(LGVN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Longeveron Inc,LGVN,Longeveron Inc股票,Longeveron Inc股票老虎,Longeveron Inc股票老虎国际,Longeveron Inc行情,Longeveron Inc股票行情,Longeveron Inc股价,Longeveron Inc股市,Longeveron Inc股票价格,Longeveron Inc股票交易,Longeveron Inc股票购买,Longeveron Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Longeveron Inc(LGVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Longeveron Inc(LGVN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}